Siglec-15 is a ligand for an unknown inhibitory receptor on cytotoxic T-cells, in the same way as PD-L1 on cancer cells or tumor stroma engages IC molecule PD-1 on T-cells [159]. This evidence concerns the gene CD274 and neoplasm.